CVS Health Corp.
CVS | NYSE
$90.24
-$0.09 (-0.10%)
At close: Oct 30, 2026, 3:59 PM ET
$90.10
-$0.14 (-0.16%)
Pre-market:
Nov 2, 2026, 7:51 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 9.05B | 4.12B | 2.94B | 1.62B | 4.49B | 5.24B | 4.59B | 5.01B | 7.2B | 7.35B | 8.37B | 8.62B | 2.96B | 4.08B | 4.3B | 3.29B | 8.28B | 8.03B | 7.9B | 7.58B | 7.21B | 7.4B |
Depreciation & Amortization | 2.18B | 1.11B | 1.15B | 1.15B | 4.63B | 4.61B | 4.6B | 4.58B | 4.55B | 4.5B | 4.37B | 4.28B | 4.2B | 4.18B | 4.23B | 4.3B | 4.38B | 4.44B | 4.51B | 4.54B | 4.52B | 4.48B |
Stock-Based Compensation | 582M | 276M | 136M | 273M | 532M | 529M | 540M | 530M | 551M | 622M | 588M | 567M | 518M | 461M | 447M | 479M | 488M | 486M | 484M | 458M | 453M | 391M |
Other Working Capital | 1.12B | -1.06B | -580M | 2.49B | 3.01B | 489M | -823M | -5.82B | -7.53B | -4.28B | 1.42B | 1.6B | 11.01B | 11.52B | 7B | 12.42B | 4.16B | 3.4B | 3.02B | 3.03B | 918M | 2.74B |
Other Non-Cash Items | 7.11B | 7.11B | 7.35B | 6.57B | 78M | 86M | -153M | 1.26B | 568M | 568M | 568M | 246M | 2.62B | 2.39B | 2.39B | 3.35B | 1.63B | 1.85B | 1.85B | 1.54B | 1.24B | 1.24B |
Deferred Income Tax | 493M | 620M | 542M | 340M | -514M | -524M | -572M | -1.23B | -907M | -851M | -479M | 12M | -1.71B | -1.71B | -2.04B | -2B | -304M | -437M | -428M | -1.19B | -839M | -701M |
Change in Working Capital | -390M | -2.9B | -1.47B | -847M | -1.66B | -1.19B | 109M | -5.54B | -3.89B | -1.3B | 15M | 383M | 11.93B | 10.65B | 6.85B | 12.71B | 4.07B | 4.57B | 3.95B | 4.9B | 1.6B | 2.63B |
Operating Cash Flow | 19.03B | 10.33B | 10.64B | 9.11B | 7.57B | 8.76B | 9.11B | 4.61B | 8.07B | 10.89B | 13.43B | 14.11B | 20.52B | 20.05B | 16.18B | 22.13B | 18.53B | 18.94B | 18.27B | 17.83B | 14.18B | 15.45B |
Capital Expenditures | -3.87B | -2.94B | -2.83B | -2.82B | -2.79B | -2.82B | -2.78B | -2.92B | -2.8B | -2.75B | -3.03B | -2.81B | -2.84B | -2.66B | -2.73B | -2.64B | -2.66B | -2.74B | -2.52B | -2.64B | -2.56B | -2.52B |
Cash Acquisitions | 118M | 8M | -7M | -10M | -161M | -90M | -95M | -205M | -211M | -9.54B | -16.61B | -15.82B | -15.79B | -8.48B | -1.39B | -2.07B | -2.11B | -69M | -146M | -167M | 634M | 503M |
Purchase of Investments | -20.72B | -15.65B | -15.01B | -13.56B | -15.6B | -15.2B | -15.19B | -15.1B | -11.33B | -10.23B | -9.04B | -7.93B | -7.24B | -6.63B | -7.75B | -8.99B | -9.4B | -10.31B | -9.96B | -10.68B | -11.52B | -11.24B |
Sales Maturities Of Investments | 17.16B | 13.01B | 12.38B | 12.36B | 12.8B | 11.73B | 10.35B | 9.82B | 8.51B | 7.99B | 7.73B | 6.74B | 6.01B | 6.05B | 6.73B | 7.22B | 7.66B | 7.64B | 7.25B | 8.24B | 7.7B | 7.36B |
Other Investing Acitivies | -407M | -415M | -403M | -394M | 64M | 92M | 101M | 100M | 96M | 65M | 68M | 54M | 63M | 147M | 85M | 101M | 104M | 91M | 122M | 191M | 167M | 96M |
Investing Cash Flow | -7.72B | -5.98B | -5.87B | -4.42B | -5.68B | -6.28B | -7.61B | -8.31B | -5.73B | -14.47B | -20.89B | -19.77B | -19.8B | -11.57B | -5.05B | -6.37B | -6.41B | -5.39B | -5.26B | -5.06B | -5.58B | -5.8B |
Debt Repayment | -6.74B | -1.7B | -1.78B | 694M | 496M | 956M | 5.06B | 3.62B | 2.54B | 4.84B | 7.93B | 8.15B | 7.43B | 1.39B | -4.21B | -6.63B | -5.37B | -6.48B | -9.27B | -9.94B | -14.03B | -11.66B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 1M | 4M | -3.02B | -3.02B | -3.02B | -3.02B | -2.01B | -3.51B | -3.52B | -3.52B | -3.5B | -2B | -2B | -2B | n/a | n/a | n/a | n/a |
Dividend Paid | -4.26B | -3.4B | -3.4B | -3.39B | -3.38B | -3.37B | -3.37B | -3.31B | -3.26B | -3.19B | -3.13B | -3.07B | -3.02B | -2.96B | -2.91B | -2.85B | -2.78B | -2.69B | -2.63B | -2.61B | -2.62B | -2.63B |
Other Financial Acitivies | -260M | -180M | -14M | 55M | 154M | 173M | 202M | 177M | 86M | 100M | -105M | -95M | 53M | -50M | 102M | 314M | 282M | 437M | 619M | 367M | 277M | 276M |
Financial Cash Flow | -10.74B | -4.93B | -4.94B | -2.48B | -2.68B | -2.24B | -1.14B | -2.54B | -3.65B | -1.27B | 2.68B | 1.47B | 947M | -5.14B | -10.52B | -11.16B | -9.87B | -10.74B | -11.27B | -12.18B | -16.36B | -14.02B |
Net Cash Flow | 507M | -639M | -234M | 2.21B | -795M | 239M | 359M | -6.24B | -1.31B | -4.85B | -4.78B | -4.19B | 1.66B | 3.34B | 614M | 7.52B | 5.16B | 5.72B | 4.64B | 595M | -7.76B | -4.37B |
Free Cash Flow | 15.16B | 7.39B | 7.81B | 6.29B | 4.78B | 5.94B | 6.33B | 1.69B | 5.27B | 8.14B | 10.4B | 11.3B | 17.67B | 17.39B | 13.45B | 19.5B | 15.87B | 16.19B | 15.75B | 15.19B | 11.62B | 12.93B |
Adj. Free Cash Flow | 14.58B | 7.12B | 7.67B | 6.02B | 4.25B | 5.41B | 5.79B | 1.16B | 4.72B | 7.52B | 9.81B | 10.74B | 17.16B | 16.93B | 13B | 19.02B | 15.38B | 15.71B | 15.26B | 14.73B | 11.17B | 12.54B |
Maintenance CapEx | -2.41B | -872.78M | -181.02M | -548.36M | -670.6M | -1.08B | -1.33B | -936.04M | -813.8M | -399.49M | -168.72M | -170.4M | -170.4M | -170.4M | -320.2M | -318.52M | -318.52M | -318.52M | -614.5M | -1.1B | -1.44B | -1.73B |
Growth CapEx | -1.46B | -2.07B | -2.65B | -2.27B | -2.12B | -1.73B | -1.45B | -1.99B | -1.99B | -2.35B | -2.86B | -2.64B | -2.67B | -2.49B | -2.41B | -2.32B | -2.35B | -2.42B | -1.91B | -1.53B | -1.12B | -793.67M |
Owner Earnings | 16.62B | 9.46B | 10.46B | 8.56B | 6.9B | 7.68B | 7.78B | 3.67B | 7.26B | 10.49B | 13.26B | 13.94B | 20.35B | 19.88B | 15.86B | 21.82B | 18.21B | 18.62B | 17.65B | 16.73B | 12.74B | 13.72B |
Add to Watchlist
Select watchlists to add or remove CVS